For further verification, the results of RQ-PCR reveal that ALOX5AP expression was significantly increased in AML patients (3.55–17.16, median 8.404) compared with controls (1.21–9.82, median 2.627) (P = 0.0017, Fig. 1d). Here, ALOX5AP is linked to acute myeloid leukemia.